<PAGE>
Registration No.
---------------
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
--------------------------
RAYTEL MEDICAL CORPORATION
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 94-2787342
----------------------------------- ------------------------------------
(State or other jurisdiction (I.R.S. employer identification no.)
of incorporation or organization)
2755 CAMPUS DRIVE, SUITE 200
SAN MATEO, CALIFORNIA 94403
------------------------------------------------------------
(Address of principal executive offices) (Zip code)
RAYTEL MEDICAL CORPORATION
1983 INCENTIVE STOCK OPTION PLAN
1990 STOCK OPTION PLAN
1995 OUTSIDE DIRECTORS STOCK OPTION PLAN
1996 EMPLOYEE STOCK PURCHASE PLAN
------------------------------------------------------------
(Full title of the plan)
RICHARD F. BADER
CHIEF EXECUTIVE OFFICER
RAYTEL MEDICAL CORPORATION
2755 CAMPUS DRIVE, SUITE 200
SAN MATEO, CALIFORNIA 94403
------------------------------------------------
(Name and address of agent for service)
Telephone number, including area code, of agent for service: (415) 349-0800
This registration statement, including all exhibits and attachments, contains 9
pages. The exhibit index may be found on page 7 of the consecutively numbered
pages of the registration statement.
This registration statement shall hereafter become effective in accordance with
Rule 462 promulgated under the Securities Act of 1933, as amended.
1
<PAGE>
- --------------------------------------------------------------------------------
CALCULATION OF REGISTRATION FEE
- --------------------------------------------------------------------------------
<TABLE>
<CAPTION>
Proposed Proposed
Title of maximum maximum
securities Amount offering aggregate Amount of
to be to be price per offering registration
registered(1) registered share(2) price(2) fee
- ------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
1983 INCENTIVE STOCK OPTION PLAN
Common Stock 443,376 $1.92 $851,281.92 $293.55
Par Value $0.001
1990 STOCK OPTION PLAN
Common Stock 551,169 $13.00 $7,165,197.00 $2,470.77
Par Value $0.001 689,797 $10.51 $7,249,766.47 $2,499.94
1995 OUTSIDE DIRECTORS STOCK OPTION PLAN
Common Stock 88,000 $13.00 $1,144,000.00 $394.49
Par Value $0.001 12,000 $11.75 $141,000.00 $48.62
1996 EMPLOYEE STOCK PURCHASE PLAN
Common Stock 100,000 $13.00 $1,300,000.00 $448.28
Par Value $0.001
TOTAL 1,884,342 $17,851,245.39 $6,155.65
</TABLE>
---------------------------------------------------
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE
Raytel Medical Corporation (the "Company") hereby incorporates by
reference in this registration statement the following documents:
(a) The Company's latest prospectus filed pursuant to Rule 424(b)
under the Securities Act of 1933, as amended (the "Securities Act") containing
audited financial
- --------------------------
(1) Includes options and rights to acquire such Common Stock.
(2) Estimated pursuant to Rule 457 solely for purposes of calculating the
registration fee. As to shares subject to outstanding but unexercised options,
the price is computed on the basis of the weighted average exercise price. As
to the remaining shares, the price is based upon the average of the high and low
prices of the Common Stock on September 6, 1996, as reported on the National
Association of Securities Dealers Automated Quotations System.
2
<PAGE>
statements for the Company's latest fiscal year. The prospectus is included in
the Company's Registration Statement on Form S-1 (Registration No. 33-97860)
which became effective on November 30, 1995.
(b) All other reports filed pursuant to Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act") since the end
of the fiscal year covered by the registrant document referred to in (a) above.
(c) The description of the Company's Common Stock contained in the
Company's Registration Statement on Form 8-A filed under the Exchange Act,
including any amendment or report filed for the purpose of updating such
description.
All documents subsequently filed by the Company pursuant to
Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of
a post-effective amendment to this registration statement which indicates that
all securities offered hereby have been sold or which deregisters all securities
remaining unsold, shall be deemed to be incorporated by reference in this
registration statement and to be a part hereof from the date of filing of such
documents.
ITEM 4. DESCRIPTION OF SECURITIES
The class of securities to be offered is registered under Section 12
of the Exchange Act.
ITEM 5. INTERESTS OF NAMED EXPERTS AND COUNSEL
Inapplicable.
ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS
Delaware law authorizes corporations to eliminate the personal
liability of directors to corporations and their stockholders for monetary
damages for breach or alleged breach of the directors' "duty of care." While
the relevant statute does not change directors' duty of care, it enables
corporations to limit available relief to equitable remedies such as injunction
or rescission. The statute has no effect on directors' duty of loyalty, acts or
omissions not in good faith or involving intentional misconduct or knowing
violations of law, illegal payment of dividends and approval of any transaction
from which a director derives an improper personal benefit.
The Company has adopted provisions in its Certificate of Incorporation
which eliminate the personal liability of its directors to the Company and its
stockholders for monetary damages for breach or alleged breach of their duty of
care. The Bylaws of the Company provide for indemnification of its directors,
officers, employees and agents to the full extent permitted by the General
Corporation Law of the State of Delaware, the Company's state of incorporation,
including those circumstances in which indemnification would otherwise be
discretionary under Delaware Law. Section 145 of the General Corporation Law of
the State of Delaware provides for indemnification in terms sufficiently
3
<PAGE>
broad to indemnify such individuals, under certain circumstances, for
liabilities (including reimbursement of expenses incurred) arising under the
Securities Act.
ITEM 7. EXEMPTION FROM REGISTRATION CLAIMED
Inapplicable.
ITEM 8. EXHIBITS
See Exhibit Index.
ITEM 9. UNDERTAKINGS
(a) RULE 415 OFFERING
The undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are
being made, a post-effective amendment to this registration statement:
(i) To include any prospectus required by Section 10(a)(3)
of the Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events
arising after the effective date of the registration statement (or the most
recent post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set forth in the
registration statement;
(iii)To include any material information with respect to the
plan of distribution not previously disclosed in the registration statement or
any material change to such information in the registration statement;
PROVIDED, HOWEVER, that paragraphs (a)(1)(i) and (a)(l)(ii) do not apply if the
registration statement is on Form S-3 or Form S-8, and the information required
to be included in a post-effective amendment by those paragraphs is contained in
periodic reports filed by the registrant pursuant to Section 13 or Section 15(d)
of the Exchange Act that are incorporated by reference in the registration
statement.
(2) That, for the purpose of determining any liability under the
Securities Act of 1933, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
(3) To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at the
termination of the offering.
4
<PAGE>
(b) FILING INCORPORATING SUBSEQUENT EXCHANGE ACT DOCUMENTS BY
REFERENCE
The undersigned registrant hereby undertakes that, for purposes
of determining any liability under the Securities Act of 1933, each filing of
the registrant's annual report pursuant to Section 13(a) or Section 15(d) of the
Exchange Act (and, where applicable, each filing of an employee benefit plan's
annual report pursuant to Section 15(d) of the Exchange Act) that is
incorporated by reference in the registration statement shall be deemed to be a
new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
(h) REQUEST FOR ACCELERATION OF EFFECTIVE DATE OR FILING OF
REGISTRATION STATEMENT ON FORM S-8
Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise,
the registrant has been advised that in the opinion of the Securities and
Exchange Commission such indemnification is against public policy as expressed
in the Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Act and will
be governed by the final adjudication of such issue.
SIGNATURE
Pursuant to the requirements of the Securities Act of 1933, as
amended, the registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements for filing on Form S-8 and has duly caused this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of San Mateo, State of California, on September 6,
1996.
Raytel Medical Corporation
By: /s/ Richard F. Bader
--------------------------------
Richard F. Bader, Chairman of
the Board of Directors and
Chief Executive Officer
5
<PAGE>
POWER OF ATTORNEY
The officers and directors of Raytel Medical Corporation whose signatures
appear below, hereby constitute and appoint Richard F. Bader and E. Payson
Smith, Jr., and each of them, their true and lawful attorneys and agents, with
full power of substitution, each with power to act alone, to sign and execute on
behalf of the undersigned any amendment or amendments to this registration
statement on Form S-8, and each of the undersigned does hereby ratify and
confirm all that each of said attorney and agent, or their or his substitutes,
shall do or cause to be done by virtue hereof. Pursuant to the requirements of
the Securities Act of 1933, as amended, this registration statement has been
signed by the following persons in the capacities indicated on September 6,
1996.
Signature Title
- --------------------------------------------------------------------------------
/s/ Richard F. Bader
- ------------------------------
Richard F. Bader Chairman of the Board of Directors and Chief
Executive Officer (Principal Executive
Officer)
/s/ Allan Zinberg
- ------------------------------
Allan Zinberg President, Chief Operating
Officer and Director
/s/ E. Payson Smith, Jr.
- ------------------------------
E. Payson Smith, Jr. Senior Vice President, Chief Financial
Officer (Principal Financial and Accounting
Officer)
/s/ Thomas J. Fogarty, M.D.
- ------------------------------
Thomas J. Fogarty, M.D. Director
/s/ Albert J. Henry
- ------------------------------
Albert J. Henry Director
/s/ Gene I. Miller
- ------------------------------
Gene I. Miller Director
/s/ F. David Rollo, M.D.
- ------------------------------
F. David Rollo, M.D. Director
/s/ Timothy J. Wollaeger
- ------------------------------
Timothy J. Wollaeger Director
6
<PAGE>
EXHIBIT INDEX
Sequentially
Numbered Page
-------------
4.1 Restated Certificate of Incorporation of the --
Company is incorporated by reference to
Exhibit 3.2 of the Registrant's Form S-1
Registration Statement (Registration
No. 33-97860) effective November 30, 1995
4.2 Bylaws of the Company are incorporated by --
reference to Exhibit 3.3 to the Registrant's
Form S-1 Registration Statement (Registration
No. 33-97860) effective November 30, 1995
5 Opinion re legality 8
23.1 Consent of Counsel (included in Exhibit 5) --
23.2 Consent of Arthur Andersen LLP 9
24 Power of Attorney (included in signature pages --
to this registration statement)
7
<PAGE>
[LETTERHEAD]
September 6, 1996
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Ladies and Gentlemen:
As legal counsel for Raytel Medical Corporation, a Delaware corporation
(the "Company"), we are rendering this opinion in connection with the
registration under the Securities Act of 1933, as amended, of up to 1,884,342
shares of the Common Stock, $0.001 par value, of the Company which may be issued
pursuant to the exercise of options and purchase rights granted under the Raytel
Medical Corporation 1983 Incentive Stock Option Plan, 1990 Stock Option Plan,
1995 Outside Directors Stock Option Plan and 1996 Employee Stock Purchase Plans
(the "Plans"). We have examined all instruments, documents and records which we
deemed relevant and necessary for the basis of our opinion hereinafter
expressed. In such examination, we have assumed the genuineness of all
signatures and the authenticity of all documents submitted to us as originals
and the conformity to the originals of all documents submitted to us as copies.
We are admitted to practice only in the State of California and we express no
opinion concerning any law other than the law of the State of California, the
corporation laws of the State of Delaware and the federal law of the United
States. As to matters of Delaware corporation law, we have based our opinion
solely upon our examination of such laws and the rules and regulations of the
authorities administering such laws, all as reported in standard, unofficial
compilations. We have not obtained opinions of counsel licensed to practice in
jurisdictions other than the State of California.
Based on such examination, we are of the opinion that the 1,884,342 shares
of Common Stock which may be issued upon exercise of options and purchase rights
granted under the Plans are duly authorized shares of the Company's Common
Stock, and, when issued against receipt of the consideration therefor in
accordance with the provisions of the Plans, will be validly issued, fully paid
and nonassessable. We hereby consent to the filing of this opinion as an
exhibit to the Registration Statement referred to above and the use of our name
wherever it appears in said Registration Statement.
Respectfully submitted,
/s/ Gray Cary Ware & Freidenrich
GRAY CARY WARE & FREIDENRICH
A Professional Corporation
8
<PAGE>
EXHIBIT 23.2
CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
As independent public accountants, we hereby consent to the incorporation by
reference in this registration statement of our report dated November 3, 1995,
included in Raytel Medical Corporation's Form S-1 for the year ended September
30, 1995.
/s/ Arthur Andersen LLP
Hartford, CT
September 3, 1996
9
